The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy
Open accessAbstract
Prognostic predictors have not been defined for progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). Subtypes of both disorders have been proposed on the basis of early clinical features. We performed a retrospective chart review to investigate the natural history of pathologically confirmed cases of PSP and MSA. Survival data and several clinically relevant milestones, namely: frequent falling, cognitive disability, unintelligible speech, severe dysphagia, dependence on wheelchair for mobility, the use of urinary catheters and placement in residential care were determined. On the basis of early symptoms, we subdivided cases with PSP into 'Richardson's syndrome' (RS) and 'PSP-parkinsonism' (PSP-P). Cases of MSA were subdivided according to the presence or absence of early autonomic failure. Sixty-nine (62.7%) of the 110 PSP cases were classified as RS and 29 (26.4%) as PSP-P. Of the 83 cases of MSA, 42 (53.2%) had autonomic failure within 2 years of disease onset. Patients with PSP had an older age of onset (P < 0.001), but similar disease duration to those with MSA. Patients with PSP reached their first clinical milestone earlier than patients with MSA (P < 0.001). Regular falls (P < 0.001), unintelligible speech (P = 0.04) and cognitive impairment (P = 0.03) also occurred earlier in PSP than in MSA. In PSP an RS phenotype, male gender, older age of onset and a short interval from disease onset to reaching the first clinical milestone were all independent predictors of shorter disease duration to death. Patients with RS also reached clinical milestones after a shorter interval from disease onset, compared to patients with PSP-P. In MSA early autonomic failure, female gender, older age of onset, a short interval from disease onset to reaching the first clinical milestone and not being admitted to residential care were independent factors predicting shorter disease duration until death. The time to the first clinical milestone is a useful prognostic predictor for survival. We confirm that RS had a less favourable course than PSP-P, and that early autonomic failure in MSA is associated with shorter survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
Diagnostic and Statistical Manual of Mental Disorders
Raber, G., & Spokas, M. (2025) · The Sage Encyclopedia of Mood and Anxiety Disorders · doi:10.4135/9781071886229.n145 · Cited by 2,764
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P., Quinn, N., Albanese, A., Ben-Shlomo, Y., Fowler, C., Kaufmann, H., Klockgether, T., Lang, A., Lantos, P., et al. (1998) · Clinical Autonomic Research · doi:10.1007/bf02309628 · Cited by 1,308
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Hughes, A. J., Daniel, S. E., Ben‐Shlomo, Y., & Lees, A. J. (2002) · Brain · doi:10.1093/brain/awf080 · Cited by 1,251
Self-citationPapp, M. I., Kahn, J. E., & Lantos, P. L. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90219-0 · Cited by 991
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P. A., Quinn, N., Albanese, A., Ben-Shlomo, Y., Fowler, C. J., Kaufmann, H., Klockgether, T., Lang, A. E., Lantos, P. L., et al. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00304-9 · Cited by 917
Hauw, J.-J., Daniel, S. E., Dickson, D., Horoupian, D. S., Jellinger, K., Lantos, P. L., McKee, A., Tabaton, M., & Litvan, I. (1994) · Neurology · doi:10.1212/wnl.44.11.2015 · Cited by 852
Multiple system atrophy: A review of 203 pathologically proven cases
Wenning, G. K., Tison, F., ben Shlomo, Y., Daniel, S. E., & Quinn, N. P. (1997) · Movement Disorders · doi:10.1002/mds.870120203 · Cited by 803
Clinical features and natural history of multiple system atrophy: An analysis of 100 cases
Wenning, G. K., Shlomo, Y. B., Magalhães, M., Danie, S. E., & Quinn, N. P. (1994) · Brain · doi:10.1093/brain/117.4.835 · Cited by 788
Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A., Watt, H. C., Kilford, L., Holton, J. L., Revesz, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 667
Self-citationPrevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study
Schrag, A., Ben-Shlomo, Y., & Quinn, N. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04137-9 · Cited by 642
A clinical rating scale for progressive supranuclear palsy
Golbe, L. I., & Ohman-Strickland, P. A. (2007) · Brain · doi:10.1093/brain/awm032 · Cited by 614
Progression and prognosis in multiple system atrophy
Watanabe, H., Saito, Y., Terao, S., Ando, T., Kachi, T., Mukai, E., Aiba, I., Abe, Y., Tamakoshi, A., Doyu, M., et al. (2002) · Brain · doi:10.1093/brain/awf117 · Cited by 598
Litvan, I., Hauw, J. J., Bartko, J. J., Lantos, P. L., Daniel, S. E., Horoupian, D. S., McKee, A., Dickson, D., Bancher, C., Tabaton, M., et al. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199601000-00010 · Cited by 475
Wenning, G. K., Colosimo, C., Geser, F., & Poewe, W. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00662-8 · Cited by 469
Love, S., Louis, D., & Ellison, D. W. (2008) · CRC Press eBooks · doi:10.1201/b22602 · Cited by 435
Williams, D. R., Holton, J. L., Strand, C., Pittman, A., de Silva, R., Lees, A. J., & Revesz, T. (2007) · Brain · doi:10.1093/brain/awm104 · Cited by 417
Self-citationLitvan, I., Mangone, C. A., McKee, A., Verny, M., Parsa, A., Jellinger, K., D'Olhaberriague, L., Chaudhuri, K. R., & Pearce, R. K. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.6.615 · Cited by 410
The natural history of degenerative ataxia: a retrospective study in 466 patients
Klockgether, T. (1998) · Brain · doi:10.1093/brain/121.4.589 · Cited by 379
Prevalence and natural history of progressive supranuclear palsy
Golbe, L. I., Davis, P. H., Schoenberg, B. S., & Duvoisin, R. C. (1988) · Neurology · doi:10.1212/wnl.38.7.1031 · Cited by 309
STRIATONIGRAL DEGENERATION: A CLINICOPATHOLOGICAL STUDY
FEARNLEY, J. M., & LEES, A. J. (1990) · Brain · doi:10.1093/brain/113.6.1823 · Cited by 296
Self-citationClinical features and natural history of progressive supranuclear palsy: A clinical cohort study
Nath, U., Ben-Shlomo, Y., Thomson, R. G., Lees, A. J., & Burn, D. J. (2003) · Neurology · doi:10.1212/01.wnl.0000052991.70149.68 · Cited by 281
Self-citationDaniel, S. E., de Bruin, V. M. S., & Lees, A. J. (1995) · Brain · doi:10.1093/brain/118.3.759 · Cited by 274
Self-citationWenning, G. K. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.434 · Cited by 260
Clinicopathological study of 35 cases of multiple system atrophy.
Wenning, G. K., Ben-Shlomo, Y., Magalhaes, M., Daniel, S. E., & Quinn, N. P. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.2.160 · Cited by 248
Maher, E. R., & Lees, A. J. (1986) · Neurology · doi:10.1212/wnl.36.7.1005 · Cited by 234
Self-citationSchulz, J. B., Klockgether, T., Petersen, D., Jauch, M., Muller-Schauenburg, W., Spieker, S., Voigt, K., & Dichgans, J. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.9.1047 · Cited by 224
Treatment of Parkinson's disease: levodopa as the first choice
Katzenschlager, R., & Lees, A. J. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1204-4 · Cited by 209
Self-citationPredictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study
Williams, D. R. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074070 · Cited by 203
Self-citationPatterns of levodopa response in Parkinson's disease: a clinico-pathological study
Kempster, P. A., Williams, D. R., Selikhova, M., Holton, J., Revesz, T., & Lees, A. J. (2007) · Brain · doi:10.1093/brain/awm142 · Cited by 191
Self-citationThe dopaminergic response in multiple system atrophy.
Hughes, A. J., Colosimo, C., Kleedorfer, B., Daniel, S. E., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.11.1009 · Cited by 176
Self-citationTada, M., Onodera, O., Tada, M., Ozawa, T., Piao, Y.-S., Kakita, A., Takahashi, H., & Nishizawa, M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.256 · Cited by 144
?Minimal change? multiple system atrophy
Wenning, G. K., Quinn, N. P., es, M. M., Mathias, C. J., & Daniel, S. E. (1994) · Movement Disorders · doi:10.1002/mds.870090206 · Cited by 102
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy
Testa, D., Monza, D., Ferrarini, M., Soliveri, P., Girotti, F., & Filippini, G. (2001) · Neurological Sciences · doi:10.1007/s100720100021 · Cited by 87
Causes of death in multiple system atrophy
Papapetropoulos, S., Tuchman, A., Laufer, D., Papatsoris, A., Papapetropoulos, N., & Mash, D. C. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103929 · Cited by 85
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy
Morris, H. R., Gibb, G., Katzenschlager, R., Wood, N. W., Hanger, D. P., Strand, C., Lashley, T., Daniel, S. E., Lees, A. J., Anderton, B. H., et al. (2002) · Brain · doi:10.1093/brain/awf109 · Cited by 83
Self-citationPapapetropoulos, S., Gonzalez, J., & Mash, D. C. (2005) · European Neurology · doi:10.1159/000086754 · Cited by 45
Autopsy patterns for Parkinson’s disease and related disorders in Olmsted County, Minnesota
Maraganore, D. M., Anderson, D. W., Bower, J. H., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.53.6.1342 · Cited by 32
Toward future therapies in progressive supranuclear palsy
Burn, D. J., & Warren, N. (2005) · Movement Disorders · doi:10.1002/mds.20546 · Cited by 21
Gibb, G., de Silva, R., Révész, T., Lees, A. J., Anderton, B. H., & Hanger, D. P. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.007 · Cited by 21
Self-citationIdiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report
Hughes, A. J., Daniel, S. E., & Lees, A. J. (1991) · Movement Disorders · doi:10.1002/mds.870060413 · Cited by 10
Self-citation
Cited by
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Self-citationClinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033118 · Cited by 1,124
Fanciulli, A., & Wenning, G. K. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1311488 · Cited by 809
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
Prusiner, S. B., Woerman, A. L., Mordes, D. A., Watts, J. C., Rampersaud, R., Berry, D. B., Patel, S., Oehler, A., Lowe, J. K., Kravitz, S. N., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514475112 · Cited by 689
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges
Williams, D. R., & Lees, A. J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70042-0 · Cited by 650
Self-citation
Metadata
- Authors
- O'Sullivan, S. S., Massey, L. A., Williams, D. R., Silveira-Moriyama, L., Kempster, P. A., Holton, J. L., Revesz, T., & Lees, A. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-02
- Volume
- 131
- Issue
- 5
- Pages
- 1362-1372
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1999865361
- Cited by
- 423
- References
- 43
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.